Insulet PODD Adjustments to Additional Paid In Capital, Purchase of Settlement Capped Call Transactions

Other financials

Revenue$761.7M+33.9%

Gross profit$529.0M+29.3%

Operating income$122.1M+37.5%

Net income$91.1M+157%

EPS (diluted)$1.30+160%

Cash & equivalents$480.4M-62.6%

Total debt$969.7M-45.5%

Total equity$1.3B-2.1%

Total assets$3.0B-15.1%

Operating cash flow$113.8M+78.4%

CapEx$24.3M+97.6%

Free cash flow$89.5M+73.8%

Market cap$10.1B-19.9%

Enterprise value$10.59B-19.4%

P/E33.3×+2.0×

P/S3.5×-2.3×

Gross margin71%+0.6pp

Operating margin17.5%+2.0pp

Net margin10.4%-7.9pp

FCF margin14.3%+1.1pp

Return on equity23%-14.9pp

Debt / equity0.7×-0.6×

Current ratio2.5×-2.0×

Reported directly by Insulet in its filing.

Tagged under the XBRL concept podd:AdjustmentsToAdditionalPaidInCapitalPurchaseOfSettlementCappedCallTransactions.

The official record: Insulet’s 10-Q, filed November 6, 2025, on SEC EDGAR. View the filing →

Connect your AI assistant and see it in context, right in your chat.

What is Insulet's adjustments to additional paid in capital, purchase of settlement capped call transactions?: Insulet (PODD) reported adjustments to additional paid in capital, purchase of settlement capped call transactions of $7.8M in Q3 2025.